Clinical Trial

Comparison of Individualized Sodium Management Versus Standard Treatment in Hemodialysis

Study acronym: SODIAH
Recruiting
View on ClinicalTrials.gov →
Summary
The SODIAH study is designed with the aim to assess the impact of isonatremic dialysis on interdialytic weight gain, fluid status, intradialytic hemodynamic stability, and incidence of intradialytic morbid events in dialysis patients. The study will be comparing the Na management option on the 6008 HD dialysis machines with the same machine without the Na management option turned on. Relevant performance and clinical data will be collected as well as information on patients' quality of life and wellbeing.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-03-25; most recent amendment 2025-12-16.
Status change: Not Yet Recruiting → Recruiting 2025-12-16
Trial Details
NCT Number NCT06341452
Lead Sponsor Fresenius Medical Care Deutschland GmbH
Conditions End Stage Renal Disease
Enrollment 130 participants
Start Date 2025-12-16
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-12-22